Microtissues in Cardiovascular Medicine: Regenerative Potential Based on a 3D Microenvironment

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Günter, Julia ^a,b   Wolint, Petra ^a,b   Bopp, Annina ^a,b   Steiger, Julia ^a,b   Cambria, Elena ^a,b   Hoerstrup, Simon P ^a,b,c,d   Emmert, Maximilian Y ^a,b,c,d  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d Wyss Translational Center Zurich   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; AUTOMATION; CARDIOVASCULAR DISEASE; CELL INTERACTION; CRYOPRESERVATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART INFARCTION; HOMEOSTASIS; HUMAN; HYPOXIA; IN VITRO STUDY; MICROTISSUE; MULTICELLULAR SPHEROID; NONHUMAN; PHENOTYPE; REGENERATIVE MEDICINE; REVIEW; SAFETY; STEM CELL; TISSUE CULTURE; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE SCAFFOLD; TISSUES;

EID: 84971280234     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/9098523     Document Type: Review

References (174)

1. A. F. G. Godier, D. Marolt, S. Gerecht, U. Tajnsek, T. P. Martens, and G. Vunjak-Novakovic, "Engineered microenvironments for human stem cells, " Birth Defects Research Part C-Embryo Today: Reviews, vol. 84, no. 4, pp. 335-347, 2008.
2. J. M. Kelm and M. Fussenegger, "Microscale tissue engineering using gravity-enforced cell assembly, " Trends in Biotechnology, vol. 22, no. 4, pp. 195-202, 2004.
3. J. M. Kelm and M. Fussenegger, "Scaffold-free cell delivery for use in regenerativemedicine, " Advanced Drug Delivery Reviews, vol. 62, no. 7-8, pp. 753-764, 2010.
4. A. Terzic and A. Behfar, "Regenerative heart failure therapy headed for optimization, " European Heart Journal, vol. 35, no. 19, pp. 1231-1234, 2014.
5. M. Y. Emmert, R. W. Hitchcock, and S. P. Hoerstrup, "Cell therapy, 3D culture systems and tissue engineering for cardiac regeneration, " Advanced Drug Delivery Reviews, vol. 69-70, pp. 254-269, 2014.
6. O. Bergmann, R. D. Bhardwaj, S. Bernard et al., "Evidence for cardiomyocyte renewal in humans, " Science, vol. 324, no. 5923, pp. 98-102, 2009.
7. V. F. M. Segers and R. T. Lee, "Stem-cell therapy for cardiac disease, " Nature, vol. 451, no. 7181, pp. 937-942, 2008.
8. A. Behfar, R. Crespo-Diaz, A. Terzic, and B. J. Gersh, "Cell therapy for cardiac repair-lessons from clinical trials, " Nature Reviews Cardiology, vol. 11, no. 4, pp. 232-246, 2014.
9. D. L. Mann, "Mechanisms and models in heart failure: A combinatorial approach, " Circulation, vol. 100, no. 9, pp. 999-1008, 1999.
10. M. Y. Emmert, P. Wolint, S. Winklhofer et al., "Transcatheter based electromechanical mapping guided intramyocardial transplantation and in vivo tracking of human stem cell based three dimensional microtissues in the porcine heart, " Biomaterials, vol. 34, no. 10, pp. 2428-2441, 2013.
11. V. Georgiadis, R. A. Knight, S. N. Jayasinghe, and A. Stephanou, "Cardiac tissue engineering: renewing the arsenal for the battle against heart disease, " Integrative Biology, vol. 6, no. 2, pp. 111-126, 2014.
12. L. Barile, E. Messina, A. Giacomello, and E. Marbán, "Endogenous cardiac stem cells, " Progress in Cardiovascular Diseases, vol. 50, no. 1, pp. 31-48, 2007.
13. P. Menasché, V. Vanneaux, A. Hagège et al., "Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report, " European Heart Journal, vol. 36, no. 30, pp. 2011-2017, 2015.
14. W. E. Wang, X. Chen, S. R. Houser, and C. Zeng, "Potential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart disease, " Clinical Science, vol. 125, no. 7, pp. 319-327, 2013.
15. M. Bauer, L. Kang, Y. Qiu et al., "Adult cardiac progenitor cell aggregates exhibit survival benefit both in vitro and in vivo, " PLoS ONE, vol. 7, no. 11, Article ID e50491, 2012.
16. M. Y. Emmert, P. Wolint, N. Wickboldt et al., "Human stemcellbased three-dimensional microtissues for advanced cardiac cell therapies, " Biomaterials, vol. 34, no. 27, pp. 6339-6354, 2013.
17. W.-Y. Lee, H.-J. Wei, W.-W. Lin et al., "Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stem-cell bodies enriched with endogenous ECM, " Biomaterials, vol. 32, no. 24, pp. 5558-5567, 2011.
18. J. M. Kelm, V. Djonov, S. P. Hoerstrup et al., "Tissue-transplant fusion and vascularization of myocardial microtissues and macrotissues implanted into chicken embryos and rats, " Tissue Engineering, vol. 12, no. 9, pp. 2541-2553, 2006.
19. C. Gentile, "Filling the gaps between the in vivo and in vitro microenvironment: engineering of spheroids for stem cell technology, " Current Stem Cell Research&Therapy, vol. 10, no. 999, pp. 1-1, 2015.
20. P. G. Layer, A. Robitzki, A. Rothermel, and E. Willbold, "Of layers and spheres: The reaggregate approach in tissue engineering, " Trends in Neurosciences, vol. 25, no. 3, pp. 131-134, 2002.
21. T.-M. Achilli, J. Meyer, and J. R. Morgan, "Advances in the formation, use and understanding of multi-cellular spheroids, " Expert Opinion on Biological Therapy, vol. 12, no. 10, pp. 1347-1360, 2012.
22. F. Gattazzo, A. Urciuolo, and P. Bonaldo, "Extracellular matrix: A dynamic microenvironment for stem cell niche, " Biochimica et Biophysica Acta, vol. 1840, no. 8, pp. 2506-2519, 2014.
23. A. Abbott, "Cell culture: biology's new dimension, " Nature, vol. 424, no. 6951, pp. 870-872, 2003.
24. T. Garg, O. Singh, S. Arora, and R. S. R. Murthy, "Scaffold: A novel carrier for cell and drug delivery, " Critical Reviews in Therapeutic Drug Carrier Systems, vol. 29, no. 1, pp. 1-63, 2012.
25. E. Fennema, N. Rivron, J. Rouwkema, C. van Blitterswijk, and J. De Boer, "Spheroid culture as a tool for creating 3D complex tissues, " Trends in Biotechnology, vol. 31, no. 2, pp. 108-115, 2013.
26. R.-Z. Lin and H.-Y. Chang, "Recent advances in three-dimensional multicellular spheroid culture for biomedical research, " Biotechnology Journal, vol. 3, no. 9-10, pp. 1172-1184, 2008.
27. M. E. Lukashev and Z. Werb, "ECM signalling: orchestrating cell behaviour and misbehaviour, " Trends in Cell Biology, vol. 8, no. 11, pp. 437-441, 1998.
28. C. M. Nelson and C. S. Chen, "Cell-cell signaling by direct contact increases cell proliferation via a PI3K-dependent signal, " FEBS Letters, vol. 514, no. 2-3, pp. 238-242, 2002.
29. S. Sart, A.-C. Tsai, Y. Li, and T. Ma, "Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications, " Tissue Engineering-Part B: Reviews, vol. 20, no. 5, pp. 365-380, 2014.
30. R. M. Tostões, S. B. Leite, M. Serra et al., "Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing, " Hepatology, vol. 55, no. 4, pp. 1227-1236, 2012.
31. L. Guo, J. Ge, Y. Zhou, S. Wang, R. C. H. Zhao, and Y. Wu, "Three-dimensional spheroid-cultured mesenchymal stemcells devoid of embolism attenuate brain stroke injury after intraarterial injection, " Stem Cells and Development, vol. 23, no. 9, pp. 978-989, 2014.
32. S. B. Seif-Naraghi, J. M. Singelyn, M. A. Salvatore et al., "Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction, " Science Translational Medicine, vol. 5, no. 173, Article ID 173ra25, 2013.
33. B. Demirbag, P. Y. Huri, G. T. Kose, A. Buyuksungur, and V. Hasirci, "Advanced cell therapies with and without scaffolds, " Biotechnology Journal, vol. 6, no. 12, pp. 1437-1453, 2011.
34. B. F. Bell, M. Schuler, S. Tosatti, M. Textor, Z. Schwartz, and B. D. Boyan, "Osteoblast response to titanium surfaces functionalized with extracellular matrix peptide biomimetics, " Clinical Oral Implants Research, vol. 22, no. 8, pp. 865-872, 2011.
35. M. T. Lam, S. Sim, X. Zhu, and S. Takayama, "The effect of continuous wavy micropatterns on silicone substrates on the alignment of skeletal muscle myoblasts and myotubes, " Biomaterials, vol. 27, no. 24, pp. 4340-4347, 2006.
36. E. Cambria, K. Renggli, C. C. Ahrens et al., "Covalentmodification of synthetic hydrogels with bioactive proteins via sortasemediated ligation, " Biomacromolecules, vol. 16, no. 8, pp. 2316-2326, 2015.
37. B. Guo, B. Lei, P. Li, and P. X. Ma, "Functionalized scaffolds to enhance tissue regeneration, " Regenerative Biomaterials, vol. 2, no. 1, pp. 47-57, 2015.
38. D. Seliktar, A. H. Zisch, M. P. Lutolf, J. L. Wrana, and J. A. Hubbel, "MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing, " Journal of Biomedical Materials Research Part A, vol. 68, no. 4, pp. 704-716, 2004.
39. A. Ito, K. Ino, T. Kobayashi, and H. Honda, "The effect of RGD peptide-conjugated magnetite cationic liposomes on cell growth and cell sheet harvesting, " Biomaterials, vol. 26, no. 31, pp. 6185-6193, 2005.
40. A. Y. Hsiao, Y.-C. Tung, X. Qu, L. R. Patel, K. J. Pienta, and S. Takayama, "384 Hanging drop arrays give excellent Zfactors and allow versatile formation of co-culture spheroids, " Biotechnology and Bioengineering, vol. 109, no. 5, pp. 1293-1304, 2012.
41. E. Messina, L. De Angelis, G. Frati et al., "Isolation and expansion of adult cardiac stem cells from human and murine heart, " Circulation Research, vol. 95, no. 9, pp. 911-921, 2004.
42. R. R. Smith, L. Barile, H. C. Cho et al., "Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens, " Circulation, vol. 115, no. 7, pp. 896-908, 2007.
43. R. R. Makkar, R. R. Smith, K. Cheng et al., "Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial, " The Lancet, vol. 379, no. 9819, pp. 895-904, 2012.
44. R. M. Sutherland, W. R. Inch, J. A. McCredie, and J. Kruuv, "A multi-component radiation survival curve using an in vitro tumour model, " International Journal of Radiation Biology, vol. 18, no. 5, pp. 491-495, 1970.
45. J. F. Petersen, L. V. McIntire, and E. T. Papoutsakis, "Shear sensitivity of cultured hybridoma cells (CRL-8018) depends on mode of growth, culture age and metabolite concentration, " Journal of Biotechnology, vol. 7, no. 3, pp. 229-246, 1988.
46. M. Ingram, G. B. Techy, R. Saroufeem et al., "Three-dimensional growth patterns of various human tumor cell lines in simulated microgravity of a NASA bioreactor, " In Vitro Cellular & Developmental Biology-Animal, vol. 33, no. 6, pp. 459-466, 1997.
47. L. A. Kunz-Schughart, M. Kreutz, and R. Knuechel, "Multicellular spheroids: A three-dimensional in vitro culture system to study tumour biology, " International Journal of Experimental Pathology, vol. 79, no. 1, pp. 1-23, 1998.
48. J. M. Yuhas, A. P. Li, A. O. Martinez, and A. J. Ladman, "A simplified method for production and growth of multicellular tumor spheroids, " Cancer Research, vol. 37, no. 10, pp. 3639-3643, 1977.
49. J. Friedrich, C. Seidel, R. Ebner, and L. A. Kunz-Schughart, "Spheroid-based drug screen: considerations and practical approach, " Nature Protocols, vol. 4, no. 3, pp. 309-324, 2009.
50. W. Metzger, D. Sossong, A. Bächle et al., "The liquid overlay technique is the key to formation of co-culture spheroids consisting of primary osteoblasts, fibroblasts and endothelial cells, " Cytotherapy, vol. 13, no. 8, pp. 1000-1012, 2011.
51. A. P. Napolitano, P. Chai, D. M. Dean, and J. R. Morgan, "Dynamics of the self-assembly of complex cellular aggregates on micromolded nonadhesive hydrogels, " Tissue Engineering, vol. 13, no. 8, pp. 2087-2094, 2007.
52. M. Akiyama, H. Nonomura, S. H. Kamil, and R. A. Ignotz, "Periosteal cell pellet culture system: A new technique for bone engineering, " Cell Transplantation, vol. 15, no. 6, pp. 521-532, 2006.
53. J. Liu, L. A. Kuznetsova, G. O. Edwards et al., "Functional three-dimensionalHepG2 aggregate cultures generated froman ultrasound trap: comparison with HepG2 spheroids, " Journal of Cellular Biochemistry, vol. 102, no. 5, pp. 1180-1189, 2007.
54. A. Sebastian, A.-M. Buckle, and G. H. Markx, "Tissue engineering with electric fields: immobilization ofmammalian cells in multilayer aggregates using dielectrophoresis, " Biotechnology and Bioengineering, vol. 98, no. 3, pp. 694-700, 2007.
55. K. Ino, A. Ito, and H. Honda, "Cell patterning using magnetite nanoparticles and magnetic force, " Biotechnology and Bioengineering, vol. 97, no. 5, pp. 1309-1317, 2007.
56. B. K. Jong, "Three-dimensional tissue culture models in cancer biology, " Seminars in Cancer Biology, vol. 15, no. 5, pp. 365-377, 2005.
57. J. M. Kelm, N. E. Timmins, C. J. Brown, M. Fussenegger, and L. K. Nielsen, "Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types, " Biotechnology and Bioengineering, vol. 83, no. 2, pp. 173-180, 2003.
58. J. M. Kelm, E. Ehler, L. K. Nielsen, S. Schlatter, J.-C. Perriard, and M. Fussenegger, "Design of artificial myocardial microtissues, " Tissue Engineering, vol. 10, no. 1-2, pp. 201-214, 2004.
59. Y.-C. Tung, A. Y. Hsiao, S. G. Allen, Y.-S. Torisawa, M. Ho, and S. Takayama, "High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array, " Analyst, vol. 136, no. 3, pp. 473-478, 2011.
60. C. R. Thoma, S. Stroebel, N. Rösch, B. Calpe, W. Krek, and J. M. Kelm, "A high-throughput-compatible 3D microtissue coculture system for phenotypic RNAi screening applications, " Journal of Biomolecular Screening, vol. 18, no. 10, pp. 1330-1337, 2013.
61. N. Mukherjee, Z. Chen, A. Sambanis, and Y. Song, "Effects of cryopreservation on cell viability and insulin secretion in a model tissue-engineered pancreatic substitute (TEPS), " Cell Transplantation, vol. 14, no. 7, pp. 449-456, 2005.
62. D. Gao and J. K. Critser, "Mechanisms of cryoinjury in living cells, " ILAR Journal, vol. 41, no. 4, pp. 187-196, 2000.
63. A. P. Van Winkle, I. D. Gates, and M. S. Kallos, "Mass transfer limitations in embryoid bodies during human embryonic stem cell differentiation, " Cells Tissues Organs, vol. 196, no. 1, pp. 34-47, 2012.
64. D. H. Edgar and D. A. Gook, "A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos, " Human Reproduction Update, vol. 18, no. 5, pp. 536-554, 2012.
65. S. Sart, T. Ma, and Y. Li, "Cryopreservation of pluripotent stem cell aggregates in defined protein-free formulation, " Biotechnology Progress, vol. 29, no. 1, pp. 143-153, 2013.
66. L. An, S. Chang, Y. Hu et al., "Efficient cryopreservation of mouse embryos by modified droplet vitrification (MDV), " Cryobiology, vol. 71, no. 1, pp. 70-76, 2015.
67. P. W. Shaw, B. J. Fuller, A. Bernard, and R. W. Shaw, "Vitrification of mouse oocytes: improved rates of survival, fertilization, and development to blastocysts, " Molecular Reproduction and Development, vol. 29, no. 4, pp. 373-378, 1991.
68. Y. Li and T. Ma, "Bioprocessing of cryopreservation for largescale banking of human pluripotent stem cells, " BioResearch Open Access, vol. 1, no. 5, pp. 205-214, 2012.
69. L. A. Marquez-Curtis, A. Janowska-Wieczorek, L. E. McGann, and J. A. Elliott, "Mesenchymal stromal cells derived fromvarious tissues: biological, clinical and cryopreservation aspects, " Cryobiology, vol. 71, no. 2, pp. 181-197, 2015.
70. J. P. Acker, J. A. W. Elliott, and L. E. McGann, "Intercellular ice propagation: experimental evidence for ice growth through membrane pores, " Biophysical Journal, vol. 81, no. 3, pp. 1389-1397, 2001.
71. I. Massie, C. Selden, H. Hodgson, B. Fuller, S. Gibbons, and G. J. Morris, "GMP cryopreservation of large volumes of cells for regenerative medicine: Active control of the freezing process, " Tissue Engineering-Part C:Methods, vol. 20, no. 9, pp. 693-702, 2014.
72. X.-H. Ma, Y. Shi, Y. Hou et al., "Slow-freezing cryopreservation of neural stem cell spheres with different diameters, " Cryobiology, vol. 60, no. 2, pp. 184-191, 2010.
73. S. Sharma, E. A. Szurek, J. S. Rzucidlo, S. S. Liour, and A. Eroglu, "Cryobanking of embryoid bodies to facilitate basic research and cell-based therapies, " Rejuvenation Research, vol. 14, no. 6, pp. 641-649, 2011.
74. F. Pampaloni, E. G. Reynaud, and E. H. K. Stelzer, "The third dimension bridges the gap between cell culture and live tissue, " Nature Reviews Molecular Cell Biology, vol. 8, no. 10, pp. 839-845, 2007.
75. G. Vunjak-Novakovic, K. O. Lui, N. Tandon, and K. R. Chien, "Bioengineering heart muscle: A paradigm for regenerative medicine, " Annual Review of Biomedical Engineering, vol. 13, pp. 245-267, 2011.
76. D.-Y. Chen, H.-J. Wei, K.-J. Lin et al., "Three-dimensional cell aggregates composed of HUVECs and cbMSCs for therapeutic neovascularization in a mouse model of hindlimb ischemia, " Biomaterials, vol. 34, no. 8, pp. 1995-2004, 2013.
77. T. Anada, J. Fukuda, Y. Sai, and O. Suzuki, "An oxygenpermeable spheroid culture system for the prevention of central hypoxia and necrosis of spheroids, " Biomaterials, vol. 33, no. 33, pp. 8430-8441, 2012.
78. H. Ota and N. Miki, "Microtechnology-based three-dimensional spheroid formation, " Frontiers in Bioscience, vol. 5, no. 1, pp. 37-48, 2013.
79. R. C. Bates, N. S. Edwards, and J. D. Yates, "Spheroids and cell survival, " Critical Reviews in Oncology Hematology, vol. 36, no. 2-3, pp. 61-74, 2000.
80. T. J. Bartosh, J. H. Ylöstalo, A. Mohammadipoor et al., "Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 31, pp. 13724-13729, 2010.
81. S. Zhang, P. Liu, L. Chen, Y. Wang, Z. Wang, and B. Zhang, "The effects of spheroid formation of adipose-derived stem cells in a microgravity bioreactor on stemness properties and therapeutic potential, " Biomaterials, vol. 41, pp. 15-25, 2015.
82. T. Korff and H. G. Augustin, "Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation, " Journal of Cell Biology, vol. 143, no. 5, pp. 1341-1352, 1998.
83. N. Sperelakis, "Cultured heart cell reaggregate model for studying cardiac toxicology, " Environmental Health Perspectives, vol. 26, pp. 243-267, 1978.
84. W.-Y. Lee, Y.-H. Chang, Y.-C. Yeh et al., "The use of injectable spherically symmetric cell aggregates self-assembled in a thermo-responsive hydrogel for enhanced cell transplantation, " Biomaterials, vol. 30, no. 29, pp. 5505-5513, 2009.
85. E. Forte, F. Miraldi, I. Chimenti et al., "TGF-dependent epithelial-to-mesenchymal transition is required to generate cardiospheres from human adult heart biopsies, " Stem Cells and Development, vol. 21, no. 17, pp. 3081-3090, 2012.
86. H. Gerhardt and C. Betsholtz, "Endothelial-pericyte interactions in angiogenesis, " Cell and Tissue Research, vol. 314, no. 1, pp. 15-23, 2003.
87. A. Armulik, A. Abramsson, and C. Betsholtz, "Endothelial/pericyte interactions, " Circulation Research, vol. 97, no. 6, pp. 512-523, 2005.
88. E. Ghafar-Zadeh, J. R. Waldeisen, and L. P. Lee, "Engineered approaches to the stemcell microenvironment for cardiac tissue regeneration, " Lab on a Chip, vol. 11, no. 18, pp. 3031-3048, 2011.
89. S. H. Bhang, S.-W. Cho, W.-G. La et al., "Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells, " Biomaterials, vol. 32, no. 11, pp. 2734-2747, 2011.
90. K. Bhadriraju and C. S. Chen, "Engineering cellular microenvironments to improve cell-based drug testing, " Drug Discovery Today, vol. 7, no. 11, pp. 612-620, 2002.
91. S. B. C. Watzka, J. Lucien, M. Shimada et al., "Selection of viable cardiomyocytes for cell transplantation using threedimensional tissue culture, " Transplantation, vol. 70, no. 9, pp. 1310-1317, 2000.
92. R. S. Ross, C. Pham, S.-Y. Shai et al., "1 Integrins participate in the hypertrophic response of rat ventricular myocytes, " Circulation Research, vol. 82, no. 11, pp. 1160-1172, 1998.
93. S. K. Kapur, X. Wang, H. Shang et al., "Human adipose stem cells maintain proliferative, synthetic and multipotential properties when suspension cultured as self-assembling spheroids, " Biofabrication, vol. 4, no. 2, Article ID 025004, 2012.
94. N.-C. Cheng, S. Wang, and T.-H. Young, "The influence of spheroid formation of human adipose-derived stem cells on chitosan films on stemness and differentiation capabilities, " Biomaterials, vol. 33, no. 6, pp. 1748-1758, 2012.
95. K. L. Christman and R. J. Lee, "Biomaterials for the treatment of myocardial infarction, " Journal of the American College of Cardiology, vol. 48, no. 5, pp. 907-913, 2006.
96. M. W. Laschke, T. E. Schank, C. Scheuer et al., "Threedimensional spheroids of adipose-derived mesenchymal stem cells are potent initiators of blood vessel formation in porous polyurethane scaffolds, " Acta Biomaterialia, vol. 9, no. 6, pp. 6876-6884, 2013.
97. L. R. Garzoni, M. I. D. Rossi, A. P. D. N. de Barros et al., "Dissecting coronary angiogenesis: 3D co-culture of cardiomyocytes with endothelial or mesenchymal cells, " Experimental Cell Research, vol. 315, no. 19, pp. 3406-3418, 2009.
98. L. G. Griffith and G. Naughton, "Tissue engineering-current challenges and expanding opportunities, " Science, vol. 295, no. 5557, pp. 1009-1014, 2002.
99. J. M. Kelm, C. D. Sanchez-Bustamante, E. Ehler et al., "VEGF profiling and angiogenesis in human microtissues, " Journal of Biotechnology, vol. 118, no. 2, pp. 213-229, 2005.
100. A. P. McGuigan and M. V. Sefton, "Vascularized organoid engineered by modular assembly enables blood perfusion, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 31, pp. 11461-11466, 2006.
101. R. K. Jain, P. Au, J. Tam, D. G. Duda, and D. Fukumura, "Engineering vascularized tissue, " Nature Biotechnology, vol. 23, no. 7, pp. 821-823, 2005.
102. S. H. Bhang, S. Lee, J.-Y. Shin, T.-J. Lee, and B.-S. Kim, "Transplantation of cord blood mesenchymal stem cells as spheroids enhances vascularization, " Tissue Engineering-Part A, vol. 18, no. 19-20, pp. 2138-2147, 2012.
103. J. H. Kim, I. S. Park, Y. Park, Y. Jung, S. H. Kim, and S.-H. Kim, "Therapeutic angiogenesis of three-dimensionally cultured adipose-derived stem cells in rat infarcted hearts, " Cytotherapy, vol. 15, no. 5, pp. 542-556, 2013.
104. W.-Y. Lee, H.-W. Tsai, J.-H. Chiang et al., "Core-shell cell bodies composed of human cbMSCs and HUVECs for functional vasculogenesis, " Biomaterials, vol. 32, no. 33, pp. 8446-8455, 2011.
105. E. C. Martinez, D.-T. Vu, J. Wang et al., "Grafts enriched with subamnion-cord-lining mesenchymal stem cell angiogenic spheroids induce post-ischemic myocardial revascularization and preserve cardiac function in failing rat hearts, " Stem Cells and Development, vol. 22, no. 23, pp. 3087-3099, 2013.
106. H.-J. Lee, H.-J. Cho, Y.-W. Kwon, Y.-B. Park, and H.-S. Kim, "Phenotypic modulation of human cardiospheres between stemness and paracrine activity, and implications for combined transplantation in cardiovascular regeneration, " Biomaterials, vol. 34, no. 38, pp. 9819-9829, 2013.
107. C.-C. Wang, C.-H. Chen, S.-M. Hwang et al., "Spherically symmetric mesenchymal stromal cell bodies inherent with endogenous extracellular matrices for cellular cardiomyoplasty, " Stem Cells, vol. 27, no. 3, pp. 724-732, 2009.
108. E. Tseliou, S. Pollan, K. Malliaras et al., "Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains, " Journal of the American College of Cardiology, vol. 61, no. 10, pp. 1108-1119, 2013.
109. W.-Y. Lee, H.-J. Wei, J.-J. Wang et al., "Vascularization and restoration of heart function in rat myocardial infarction using transplantation of human cbMSC/HUVEC core-shell bodies, " Biomaterials, vol. 33, no. 7, pp. 2127-2136, 2012.
110. A. Alajati, A. M. Laib, H. Weber et al., "Spheroid-based engineering of a human vasculature in mice, " Nature Methods, vol. 5, no. 5, pp. 439-445, 2008.
111. J. Li, R. Tao, W. Wu et al., "3D PLGA scaffolds improve differentiation and function of bone marrow mesenchymal stemcell-derived hepatocytes, " Stem Cells andDevelopment, vol. 19, no. 9, pp. 1427-1436, 2010.
112. K. von der Mark, V. Gauss, H. von der Mark, and P. Mueller, "Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture, " Nature, vol. 267, no. 5611, pp. 531-532, 1977.
113. W. Wang, K. Itaka, S. Ohba et al., "3D spheroid culture system on micropatterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells, " Biomaterials, vol. 30, no. 14, pp. 2705-2715, 2009.
114. L. G. Griffith and M. A. Swartz, "Capturing complex 3D tissue physiology in vitro, " Nature ReviewsMolecular Cell Biology, vol. 7, no. 3, pp. 211-224, 2006.
115. R. Gaetani, D. A. M. Feyen, P. A. Doevendans et al., "Different types of cultured human adult cardiac progenitor cells have a high degree of transcriptome similarity, " Journal of Cellular and Molecular Medicine, vol. 18, no. 11, pp. 2147-2151, 2015.
116. J. E. Frith, B. Thomson, and P. G. Genever, "Dynamic threedimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential, " Tissue Engineering Part C: Methods, vol. 16, no. 4, pp. 735-749, 2010.
117. L. Guo, Y. Zhou, S. Wang, and Y. Wu, "Epigenetic changes of mesenchymal stem cells in three-dimensional (3D) spheroids, " Journal of Cellular and Molecular Medicine, vol. 18, no. 10, pp. 2009-2019, 2014.
118. L. A. Mylotte, A. M. Duffy, M. Murphy et al., "Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment, " Stem Cells, vol. 26, no. 5, pp. 1325-1336, 2008.
119. M. V. Gustafsson, X. Zheng, T. Pereira et al., "Hypoxia requires Notch signaling to maintain the undifferentiated cell state, " Developmental Cell, vol. 9, no. 5, pp. 617-628, 2005.
120. I. A. Potapova, P. R. Brink, I. S. Cohen, and S. V. Doronin, "Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells, " Journal of Biological Chemistry, vol. 283, no. 19, pp. 13100-13107, 2008.
121. F. Oltolina, A. Zamperone, D. Colangelo et al., "Human cardiac progenitor spheroids exhibit enhanced engraftment potential, " PLOS ONE, vol. 10, no. 9, Article IDe0137999, 2015.
122. J. H. Ylöstalo, T. J. Bartosh, K. Coble, and D. J. Prockop, "Human mesenchymal stem/stromal cells cultured as spheroids are selfactivated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype, " StemCells, vol. 30, no. 10, pp. 2283-2296, 2012.
123. P. Beauchamp, W. Moritz, J. M. Kelm et al., "Development and characterization of a scaffold-free 3D spheroid model of induced pluripotent stem cell-derived human cardiomyocytes, " Tissue Engineering Part C: Methods, vol. 21, no. 8, pp. 852-861, 2015.
124. L. Just, A. Kürsten, T. Borth-Bruhns et al., "Formation of threedimensional fetal myocardial tissue cultures from rat for longterm cultivation, " Developmental Dynamics, vol. 235, no. 8, pp. 2200-2209, 2006.
125. E. Yechiel and Y. Barenholz, "Cultured heart cell reaggregates: A model for studying relationships between aging and lipid composition, " Biochimica et Biophysica Acta (BBA)-Biomembranes, vol. 859, no. 1, pp. 105-109, 1986.
126. J. C. Mitrius and S. M. Vogel, "Doxorubicin-induced automaticity in cultured chick heart cell aggregates, " Cancer Research, vol. 50, no. 14, pp. 4209-4215, 1990.
127. W. T. Clusin, "Correlation between relaxation and automaticity in embryonic heart cell aggregates, " Proceedings of the National Academy of Sciences of the United States of America, vol. 77, no. 1, pp. 679-683, 1980.
128. R. G. Gourdie, Y. Wei, D. Kim, S. C. Klatt, and T. Mikawa, "Endothelin-induced conversion of embryonic heart muscle cells into impulse-conducting Purkinje fibers, " Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 12, pp. 6815-6818, 1998.
129. B. R. Desroches, P. Zhang, B.-R. Choi et al., "Functional scaffold-free 3-D cardiac microtissues: A novel model for the investigation of heart cells, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 302, no. 10, pp. H2031-H2042, 2012.
130. S.-T. Lee, A. J. White, S. Matsushita et al., "Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction, " Journal of the American College of Cardiology, vol. 57, no. 4, pp. 455-465, 2011.
131. T. J. Bartosh, Z. Wang, A. A. Rosales, S. Dan Dimitrijevich, and R. S. Roque, "3D-model of adult cardiac stem cells promotes cardiac differentiation and resistance to oxidative stress, " Journal of Cellular Biochemistry, vol. 105, no. 2, pp. 612-623, 2008.
132. R. Gallet, E. Tseliou, J. Dawkins et al., "Intracoronary delivery of self-assembling heart-derived microtissues (cardiospheres) for prevention of adverse remodeling in a pig model of convalescent myocardial infarction, " Circulation: Cardiovascular Interventions, vol. 8, no. 5, Article ID e002391, 2015.
133. K. Yee, K. Malliaras, H. Kanazawa et al., "Allogeneic cardiospheres delivered via percutaneous transendocardial injection increase viable myocardium, decrease scar size, and attenuate cardiac dilatation in porcine ischemic cardiomyopathy, " PLoS ONE, vol. 9, no. 12, Article IDe113805, 2014.
134. X.-P. Huang, Z. Sun, Y. Miyagi et al., "Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair, " Circulation, vol. 122, no. 23, pp. 2419-2429, 2010.
135. P. Lohan, C. M. Coleman, J. M. Murphy, M. D. Griffin, T. Ritter, and A. E. Ryan, "Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned" Stem Cell Research & Therapy, vol. 5, no. 4, pp. 1-11, 2014.
136. J. M. Hare, J. E. Fishman, G. Gerstenblith et al., "Comparison of allogeneic vs autologous bonemarrow-derivedmesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial, " Journal of the American Medical Association, vol. 308, no. 22, pp. 2369-2379, 2012.
137. R. Makkar, R. Schatz, J. Traverse et al., "Abstract 20536: Allogeneic heart stem cells to achieve myocardial regeneration (ALLSTAR): the one year phase I results, " Circulation, vol. 130, supplement 2, p. A20536, 2014.
138. S. Sakai, K. Inamoto, Y. Liu, S. Tanaka, S. Arii, and M. Taya, "Multicellular tumor spheroid formation in duplex microcapsules for analysis of chemosensitivity, " Cancer Science, vol. 103, no. 3, pp. 549-554, 2012.
139. D. Orlic, J. A. N. Kajstura, S. Chimenti, D. M. Bodine, A. Leri, and P. Anversa, "Transplanted adult bone marrow cells repair myocardial infarcts in mice, " Annals of the New York Academy of Sciences, vol. 938, pp. 221-230, 2001.
140. A. Mirsaidi, K. Genelin, J. R. Vetsch et al., "Therapeutic potential of adipose-derived stromal cells in age-related osteoporosis, " Biomaterials, vol. 35, no. 26, pp. 7326-7335, 2014.
141. T. Schubert, S. Anders, E. Neumann et al., "Long-term effects of chondrospheres on cartilage lesions in an autologous chondrocyte implantation model as investigated in the SCID mouse model, " International Journal ofMolecularMedicine, vol. 23, no. 4, pp. 455-460, 2009.
142. K. K. Meissner, D. L. Kirkham, and L. C. Doering, "Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's, " Brain Research, vol. 1057, no. 1-2, pp. 105-112, 2005.
143. N. Lumelsky, O. Blondel, P. Laeng, I. Velasco, R. Ravin, and R. McKay, "Differentiation of embryonic stem cells to insulinsecreting structures similar to pancreatic islets, " Science, vol. 292, no. 5520, pp. 1389-1394, 2001.
144. Y. Sakai, S. Yamagami, and K. Nakazawa, "Comparative analysis of gene expression in rat liver tissue and monolayer-and spheroid-cultured hepatocytes, " Cells Tissues Organs, vol. 191, no. 4, pp. 281-288, 2010.
145. S. F. Abu-Absi, J. R. Friend, L. K. Hansen, and W.-S. Hu, "Structural polarity and functional bile canaliculi in rat hepatocyte spheroids, " Experimental Cell Research, vol. 274, no. 1, pp. 56-67, 2002.
146. K. Urbanek, D. Torella, F. Sheikh et al., "Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 24, pp. 8692-8697, 2005.
147. P. Menasché, "Stem cells for clinical use in cardiovascular medicine: current limitations and future perspectives, " Thrombosis and Haemostasis, vol. 94, no. 4, pp. 697-701, 2005.
148. J. V. Terrovitis, R. R. Smith, and E. Marbán, "Assessment and optimization of cell engraftment after transplantation into the heart, " Circulation Research, vol. 106, no. 3, pp. 479-494, 2010.
149. K. H. Wu, X. M. Mo, Z. C. Han, and B. Zhou, "Stem cell engraftment and survival in the ischemic heart, " Annals of Thoracic Surgery, vol. 92, no. 5, pp. 1917-1925, 2011.
150. H. Zhang, H. Chen, W. Wang, Y. Wei, and S. Hu, "Cell survival and redistribution after transplantation into damaged myocardium, " Journal of Cellular and Molecular Medicine, vol. 14, no. 5, pp. 1078-1082, 2010.
151. E. Hill, T. Boontheekul, and D. J. Mooney, "Regulating activation of transplanted cells controls tissue regeneration, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 8, pp. 2494-2499, 2006.
152. T.-S. Li, K. Cheng, S.-T. Lee et al., "Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency formyocardial repair, " Stem Cells, vol. 28, no. 11, pp. 2088-2098, 2010.
153. T. E. Robey, M. K. Saiget, H. Reinecke, and C. E. Murry, "Systems approaches to preventing transplanted cell death in cardiac repair, " Journal of Molecular and Cellular Cardiology, vol. 45, no. 4, pp. 567-581, 2008.
154. E. C. Perin and G. V. Silva, "Cell-based therapy for chronic ischemic heart disease-a clinical perspective, " Cardiovascular Therapeutics, vol. 29, no. 3, pp. 211-217, 2011.
155. D. R. Davis, R. R. Smith, and E. Marbán, "Human cardiospheres are a source of stem cells with cardiomyogenic potential, " Stem Cells, vol. 28, no. 5, pp. 903-904, 2010.
156. I. Chimenti, R. R. Smith, T.-S. Li et al., "Relative roles of direct regeneration versus paracrine effects of human cardiospherederived cells transplanted into infarcted mice, " Circulation Research, vol. 106, no. 5, pp. 971-980, 2010.
157. A. P. Beltrami, L. Barlucchi, D. Torella et al., "Adult cardiac stem cells are multipotent and support myocardial regeneration, " Cell, vol. 114, no. 6, pp. 763-776, 2003.
158. K. Urbanek, D. Cesselli, M. Rota et al., "Stem cell niches in the adult mouse heart, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 24, pp. 9226-9231, 2006.
159. P. Anversa, J. Kajstura, and A. Leri, "If I can stop one heart from breaking, " Circulation, vol. 115, no. 7, pp. 829-832, 2007.
160. H.-J. Cho, H.-J. Lee, Y.-J. Chung et al., "Generation of human secondary cardiospheres as a potent cell processing strategy for cell-based cardiac repair, " Biomaterials, vol. 34, no. 3, pp. 651-661, 2013.
161. D. Nguyen, T. Hookway, Q. Wu et al., "Microscale generation of cardiospheres promotes robust enrichment of cardiomyocytes derived from human pluripotent stem cells, " Stem Cell Reports, vol. 3, no. 2, pp. 260-268, 2014.
162. P. J. Psaltis, A. C. W. Zannettino, S. G. Worthley, and S. Gronthos, "Concise review: mesenchymal stromal cells: Potential for cardiovascular repair, " Stem Cells, vol. 26, no. 9, pp. 2201-2210, 2008.
163. C.-H. Yoon, M. Koyanagi, K. Iekushi et al., "Mechanism of improved cardiac function after bonemarrowmononuclear cell therapy: role of cardiovascular lineage commitment, " Circulation, vol. 121, no. 18, pp. 2001-2011, 2010.
164. G. Matsumura, S. Miyagawa-Tomita, T. Shin'oka, Y. Ikada, and H. Kurosawa, "First evidence that bonemarrow cells contribute to the construction of tissue-engineered vascular autografts in vivo, " Circulation, vol. 108, no. 14, pp. 1729-1734, 2003.
165. P. Au, J. Tam, D. Fukumura, and R. K. Jain, "Bone marrow derived mesenchymal stem cells facilitate engineering of longlasting functional vasculature, " Blood, vol. 111, no. 9, pp. 4551-4558, 2008.
166. K. Malliaras and E. Marbán, "Cardiac cell therapy: where we've been, where we are, and where we should be headed, " British Medical Bulletin, vol. 98, no. 1, pp. 161-185, 2011.
167. J. M. Kelm, V. Djonov, L. M. Ittner et al., "Design of customshaped vascularized tissues using microtissue spheroids as minimal building units, " Tissue Engineering, vol. 12, no. 8, pp. 2151-2160, 2006.
168. G. D. Yancopoulos, S. Davis, N. W. Gale, J. S. Rudge, S. J. Wiegand, and J. Holash, "Vascular-specific growth factors and blood vessel formation, " Nature, vol. 407, no. 6801, pp. 242-248, 2000.
169. M. Nomi, A. Atala, P. De Coppi, and S. Soker, "Principals of neovascularization for tissue engineering, "Molecular Aspects of Medicine, vol. 23, no. 6, pp. 463-483, 2002.
170. J. M. Kelm, V. Lorber, J. G. Snedeker et al., "A novel concept for scaffold-free vessel tissue engineering: self-assembly of microtissue building blocks, " Journal of Biotechnology, vol. 148, no. 1, pp. 46-55, 2010.
171. V. Mironov, R. P. Visconti, V. Kasyanov, G. Forgacs, C. J. Drake, and R. R. Markwald, "Organ printing: tissue spheroids as building blocks, " Biomaterials, vol. 30, no. 12, pp. 2164-2174, 2009.
172. V. Karantalis, V. Y. Suncion-Loescher, L. Bagno et al., "Synergistic effects of combined cell therapy for chronic ischemic cardiomyopathy, " Journal of theAmericanCollege of Cardiology, vol. 66, no. 18, pp. 1990-1999, 2015.
173. O. Frey, P. M. Misun, D. A. Fluri, J. G. Hengstler, and A. Hierlemann, "Reconfigurable microfluidic hanging drop network for multi-tissue interaction and analysis, " Nature Communications, vol. 5, article 4250, 2014.
174. I. Wagner, E.-M. Materne, S. Brincker et al., "A dynamic multiorgan-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture, " Lab on a Chip, vol. 13, no. 18, pp. 3538-3547, 2013.